168 related articles for article (PubMed ID: 7917917)
1. A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.
Warren HW; Anderson JH; O'Gorman P; Kane E; Kerr DJ; Cooke TG; McArdle CS
Br J Cancer; 1994 Oct; 70(4):677-80. PubMed ID: 7917917
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
[TBL] [Abstract][Full Text] [Related]
3. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
[TBL] [Abstract][Full Text] [Related]
5. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases.
Howell JD; McArdle CS; Kerr DJ; Buckles J; Ledermann JA; Taylor I; Gallagher HJ; Budden J
Br J Cancer; 1997; 76(10):1390-3. PubMed ID: 9374389
[TBL] [Abstract][Full Text] [Related]
8. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Link KH; Sunelaitis E; Kornmann M; Schatz M; Gansauge F; Leder G; Formentini A; Staib L; Pillasch J; Beger HG
Cancer; 2001 Dec; 92(11):2746-53. PubMed ID: 11753947
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas.
Lorenz M; Mueller HH; Mattes E; Gassel HJ; Junginger T; Saeger HD; Schramm H; Staib-Sebler E; Vetter G; Heinrich S; Köhne CH;
Ann Oncol; 2001 Mar; 12(3):321-5. PubMed ID: 11332142
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
Neyns B; Van Nieuwenhove Y; Aerts M; Fontaine C; Vermeij J; Schallier D; Decoster L; De Mey J; Vandenbroucke F; Hoorens A; Delvaux G; De Gréve J
Anticancer Res; 2006; 26(1B):611-9. PubMed ID: 16739329
[TBL] [Abstract][Full Text] [Related]
13. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study.
Carnaghi C; Santoro A; Rimassa L; Doci R; Rosati R; Pedicini V; Gullo G; Zuradelli M; Abbadessa G; Morenghi E; Marcon I; Garassino I
Invest New Drugs; 2007 Oct; 25(5):479-85. PubMed ID: 17492399
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases.
Lorenz M; Staib-Sebler E; Gog C; Petrowsky H; Köhne CH; Encke A
Oncology; 1998; 55(1):53-8. PubMed ID: 9428376
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
[TBL] [Abstract][Full Text] [Related]
17. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin.
Klotz HP; Weder W; Largiadèr F
Helv Chir Acta; 1993 Sep; 60(1-2):283-6. PubMed ID: 8226075
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter phase II study of the Liver Metastases Study Group of weekly intra-arterial 24-hour high dose therapy with 5-FU and folinic acid (FA) in liver metastases of colorectal tumors].
Staib-Sebler E; Müller HH; Mattes P; Junginger T; Saeger HD; Lorenz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1441-4. PubMed ID: 9931906
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.
Fallik D; Ychou M; Jacob J; Colin P; Seitz JF; Baulieux J; Adenis A; Douillard JY; Couzigou P; Mahjoubi R; Ducreux M; Mahjoubi M; Rougier P
Ann Oncol; 2003 Jun; 14(6):856-63. PubMed ID: 12796022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
